Next quarter’s earnings estimate for 9989 is HK$0.02 with a range of HK$0.02 to HK$0.02. The previous quarter’s EPS was HK$0.09. 9989 beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 55.77% of the time in the same period. In the last calendar year 9989 has Outperformed its overall industry.

9989 Sales Forecast

Next quarter’s sales forecast for 9989 is HK$1.47B with a range of HK$1.47B to HK$1.47B. The previous quarter’s sales results were HK$1.34B. 9989 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.15% of the time in the same period. In the last calendar year 9989 has Preformed in-line its overall industry.

9989 Analyst Recommendation Trends

Currently, no data available

Please return soon. This page is being updated.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

9989 Stock Forecast FAQ

What is HK:9989’s average 12-month price target, according to analysts?

Currently, no data Available

What is HK:9989’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for HK:9989, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H a Buy, Sell or Hold?

Currently, no data Available

What is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s share price target?

Currently, no data Available

What do analysts say about Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H?

To buy shares of HK:9989, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing